KINEVAC Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
When do Kinevac patents expire, and when can generic versions of Kinevac launch?
Kinevac is a drug marketed by Bracco and is included in one NDA. There is one patent protecting this drug.
This drug has ten patent family members in eight countries.
The generic ingredient in KINEVAC is sincalide. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the sincalide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Kinevac
A generic version of KINEVAC was approved as sincalide by MAIA PHARMS INC on November 22nd, 2022.
Summary for KINEVAC
International Patents: | 10 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 45 |
Clinical Trials: | 1 |
Patent Applications: | 2,084 |
Drug Prices: | Drug price information for KINEVAC |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for KINEVAC |
What excipients (inactive ingredients) are in KINEVAC? | KINEVAC excipients list |
DailyMed Link: | KINEVAC at DailyMed |


Recent Clinical Trials for KINEVAC
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Penn State University | N/A |
Memorial Health University Medical Center | N/A |
Temple University | N/A |
Pharmacology for KINEVAC
Drug Class | Cholecystokinin Analog |
Anatomical Therapeutic Chemical (ATC) Classes for KINEVAC
US Patents and Regulatory Information for KINEVAC
KINEVAC is protected by one US patents.
Patents protecting KINEVAC
Sincalide formulations
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | KINEVAC | sincalide | INJECTABLE;INJECTION | 017697-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for KINEVAC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bracco | KINEVAC | sincalide | INJECTABLE;INJECTION | 017697-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Bracco | KINEVAC | sincalide | INJECTABLE;INJECTION | 017697-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for KINEVAC
See the table below for patents covering KINEVAC around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | S4813114 | ⤷ Try a Trial | |
Denmark | 132074 | ⤷ Try a Trial | |
European Patent Office | 1631305 | FORMULATIONS A BASE DE SINCALIDE (SINCALIDE FORMULATIONS) | ⤷ Try a Trial |
Australia | 2003304382 | Sincalide formulations | ⤷ Try a Trial |
Canada | 2503982 | FORMULATIONS A BASE DE SINCALIDE (SINCALIDE FORMULATIONS) | ⤷ Try a Trial |
France | 2007810 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |